Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Jan
31
2019
OIG Advisory Opinion No. 19-02 Allows Pharmaceutical Manufacturer to Temporarily Loan Smartphones to Financially Needy Patients to Receive Data from a Digestible Medication Sensor Robinson & Cole LLP
Jun
16
2023
Privacy Tip #364 – Montana Enacts Genetic Information Privacy Law Robinson & Cole LLP
Sep
21
2023
Joint Advisory Warns of Snatch Ransomware Robinson & Cole LLP
Dec
14
2021
CMS Issues Memorandum Stating It Will Not Enforce Its COVID-19 Vaccine Mandate While There are Court-Ordered Injunctions in Place Robinson & Cole LLP
Oct
7
2021
Drones in Agriculture May Keep the Farm Going Robinson & Cole LLP
Jul
12
2019
Connecticut Legislature Modifies Statutes Relevant to Preventing and Treating Opioid Use Disorder Robinson & Cole LLP
Sep
24
2019
DOJ Reaches $21.36 Million Agreement with Compounding Pharmacy, Two of its Executives, and Managing Private Equity Firm to Resolve FCA Allegations Robinson & Cole LLP
Dec
27
2018
California Court of Appeal Rejects ABC Interpretation of “Single Beverage Condition” Mitchell Silberberg & Knupp LLP
Jan
5
2020
EU Court Rules Cannabis Trademark Unregistrable as Contrary to Public Policy Carlton Fields
Feb
10
2020
Canna We Talk Cannabis? Cybersecurity Risks Bring Growing Pains to Cannabis Businesses [PODCAST] Carlton Fields
Jan
15
2019
Court Enforces Arbitration Subpoena Against Third-Party Walgreens in Pharmaceutical Drug Overcharge Dispute Carlton Fields
Oct
11
2019
Cannabis Consumer Class Actions: The Implicit and Indispensable Ascertainability Requirement Carlton Fields
Dec
18
2018
Belch! Ocean Spray Price Premium Damages Model Passes Comcast Scrutiny Carlton Fields
Apr
17
2019
Senate Follows House Seeking to Make Cannabis Banking "S.A.F.E." Carlton Fields
Oct
22
2019
New York Court Compels Arbitration of Commercial Marijuana Dispute Carlton Fields
Jun
11
2019
No Soup for You! Carlton Fields
Aug
23
2019
Court Remands Arbitration Award to Arbitrator for Clarification Carlton Fields
Jan
29
2020
House Members Strongly Urge Senate Banking Committee to Make “Legal” Cannabis SAFE for Banking Carlton Fields
Aug
8
2019
Canna We Talk Cannabis? Emerging Topics in Cannabis Law Carlton Fields
Feb
19
2019
In re Celexa and Lexapro – The First Circuit Weighs in on China Agritech and American Pipe Tolling Pierce Atwood LLP
Aug
22
2019
Sometimes You Feel Like a Nut Pierce Atwood LLP
May
11
2020
COVID-19: The Latest Plans for Reopening Maine’s Economy Pierce Atwood LLP
Aug
23
2022
The Dormant Commerce Clause and Discrimination in Illegal Interstate Markets Pierce Atwood LLP
Mar
8
2019
Clarity on the Horizon for CBD Food Products? FDA Commissioner Indicates a Path Forward Pierce Atwood LLP
Apr
1
2024
Dictionaries and the Law – Hunting, Poaching, and the Right to Food Pierce Atwood LLP
Nov
15
2019
EPA Proposes Withdrawal of Maine Fish Consumption Water Quality Standards Pierce Atwood LLP
Dec
20
2018
2018 Farm Bill Signed into Law – Includes Major Changes Involving Hemp Pierce Atwood LLP
Oct
6
2019
FTC Courtesy Warnings to CBD Marketers About Unsubstantiated Claims Likely Drawing to an End Hinch Newman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins